topic

Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
Xinyue Dong, Jun Ren, Zohreh Amoozgar, Somin Lee, Meenal Datta, Sylvie Roberge, Mark Duquette, Dai Fukumura, Rakesh K Jain

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005583; DOI: 10.1136/jitc-2022-005583
FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer
Yang Zhang, Fan Huo, Qiang Cao, Ru Jia, Qiju Huang, Zhu A Wang, Dan Theodorescu, Qiang Lv, Pengchao Li, Chao Yan

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003939; DOI: 10.1136/jitc-2021-003939
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma
Robert I Haddad, Tanguy Y Seiwert, Laura Q M Chow, Shilpa Gupta, Jared Weiss, Iris Gluck, Joseph P Eder, Barbara Burtness, Makoto Tahara, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Andrew Albright, Robin Mogg, Mark Ayers, Lingkang Huang, Jared Lunceford, Razvan Cristescu, Jonathan Cheng, Ranee Mehra

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003026; DOI: 10.1136/jitc-2021-003026
Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy
Priya Rangan, Anna Mondino

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004147; DOI: 10.1136/jitc-2021-004147
Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity
Jin-Yan Wang, Hengyu Chen, Shu-Zhen Dai, Feng-Ying Huang, Ying-Ying Lin, Cai-Chun Wang, Lei Li, Wu-Ping Zheng, Guang-Hong Tan

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003950; DOI: 10.1136/jitc-2021-003950
Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis
Tianyu Tang, Xing Huang, Gang Zhang, Minghao Lu, Zhengtao Hong, Meng Wang, Junming Huang, Xiao Zhi, Tingbo Liang

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004129; DOI: 10.1136/jitc-2021-004129
Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?
Roger Sun, Théophraste Henry, Adrien Laville, Alexandre Carré, Anthony Hamaoui, Sophie Bockel, Ines Chaffai, Antonin Levy, Cyrus Chargari, Charlotte Robert, Eric Deutsch

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004848; DOI: 10.1136/jitc-2022-004848
1α,25(OH)₂D₃ reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells
Peng Li, Xinhai Zhu, Guangchao Cao, Ruan Wu, Ke Li, Wenhui Yuan, Biyun Chen, Guodong Sun, Xichun Xia, Hua Zhang, Xiao Wang, Zhinan Yin, Ligong Lu, Yunfei Gao

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003477; DOI: 10.1136/jitc-2021-003477
Correction: Cancer immunotherapy in special challenging populations: recommendations of the advisory Committee of Spanish Melanoma Group (GEM)
Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e001664corr1; DOI: 10.1136/jitc-2020-001664corr1
Accumulation of T-cell-suppressive PD-L1^high extracellular vesicles is associated with GvHD and might impact GvL efficacy
Rebecca Baur, Franziska Karl, Romy Böttcher-Loschinski, Andrej Stoll, Simon Völkl, Andreas Gießl, Cindy Flamann, Heiko Bruns, Ursula Schlötzer-Schrehardt, Martin Böttcher, Denis M Schewe, Thomas Fischer, Regina Jitschin, Andreas Mackensen, Dimitrios Mougiakakos

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e006362; DOI: 10.1136/jitc-2022-006362

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages